Panel Discussion

Time: 7:10 pm
day: Almac Diagnostic Services Engager Cambridge


  • Explore different pharma approaches to clinical trials and assay development relating to oncology and chronic disease indications
  • Address the challenges & opportunities of design, validation and implementation of clinical trial assays from both Pharma and Diagnostic company perspectives
  • Discuss regulatory challenges around the latest thinking on IVDR Europe and impact in the industry
  • Explore how to maximise the success of biomarker driven clinical trials globally, including a focus on the importance of China